Team:SDU-Denmark/Tour71

Medical aspects

Although there is no doubt that peptide aptamers are potential tivals of traditional antibodies in medicine and therapy, some challenges have to accomodated before they can be implemented clinically.

Size of the peptide

The bigger molecule the larger risk of immunogenicity.

Effector mechanism

Half-life